Company Filing History:
3 out of 113 
2 out of 2,405 
1 out of 1,457 
Years Active: 2014-2022
Title: Innovations and Contributions of Inventor Andrew Beck
Introduction
Andrew Beck is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. With a total of four patents to his name, Beck's work focuses on innovative therapeutic applications.
Latest Patents
Among his latest patents is an invention related to antibody drug conjugates for anti-inflammatory applications. This patent describes ADCs that comprise an antibody conjugated to an anti-inflammatory therapeutic agent via a phosphate-based linker, which offers tunable extracellular and intracellular stability. Another significant patent involves prostate-specific membrane antigen (PSMA) antibody drug conjugates. This invention relates to PSMA antibodies and ADCs that include at least one non-naturally-encoded amino acid. The patent further discloses αPSMA antibodies with modifications and methods for using these non-natural amino acid antibody drug conjugates in therapeutic and diagnostic applications.
Career Highlights
Andrew Beck has worked with prominent companies in the biotechnology sector, including Ambrx, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Beck has collaborated with notable colleagues in his field, including Ying Sun and Nick Knudsen. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
In summary, Andrew Beck is a distinguished inventor whose work in antibody drug conjugates has the potential to revolutionize therapeutic applications. His contributions to biotechnology continue to pave the way for advancements in medical treatments.